AngioDynamics (ANGO) reported a quarterly loss of $0.07 per share, better than the Zacks Consensus Estimate loss of $0.11. The loss widened versus a year ago ($0.03 per share). Overall, the earnings print beat expectations modestly, which is likely to provide limited near-term support versus a wider deterioration trend.
AngioDynamics (ANGO) reported a quarterly loss of $0.07 per share, better than the Zacks Consensus Estimate loss of $0.11. The loss widened versus a year ago ($0.03 per share). Overall, the earnings print beat expectations modestly, which is likely to provide limited near-term support versus a wider deterioration trend.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
